XML 158 R30.htm IDEA: XBRL DOCUMENT

Financing for JD Health	12 Months Ended
Financing for JD Health	Dec. 31, 2019
Financing For Subsidiary Group
Financing for JD Health	2 4 . Financing for JD Health In May 2019, the Group’s healthcare subsidiary, JD Health International, Inc. (“JD Health”) entered into definitive agreements for the non-redeemable series A preferred share financing (“JD Health Series A Preferred Shares”) with a group of third-party investors. The total amount of financing raised wa s US$931 million, representing 13.5% of the ownership of JD Health on a fully diluted basis. The Group determined that JD Health Series A Preferred Shares should be classified as non-controlling interests upon its issuance since they were not redeemable by the holders. As of December 31, 2019, among the proceeds received, RMB1,045,400 was recorded as non-controlling interests and RMB5,232,343 was recorded as additional paid-in capital.